Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.

MLA

Karuna, Shelly, et al. “Neutralizing Antibody Responses over Time in Demographically and Clinically Diverse Individuals Recovered from SARS-CoV-2 Infection in the United States and Peru: A Cohort Study.” PLoS Medicine, vol. 18, no. 12, Dec. 2021, pp. 1–25. EBSCOhost, https://doi.org/10.1371/journal.pmed.1003868.

APA

Karuna, S., Li, S. S., Grant, S., Walsh, S. R., Frank, I., Casapia, M., Trahey, M., Hyrien, O., Fisher, L., Miner, M. D., Randhawa, A. K., Polakowski, L., Kublin, J. G., Corey, L., Montefiori, D., & HVTN 405/HPTN 1901 Study Team. (2021). Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Medicine, 18(12), 1–25. https://doi.org/10.1371/journal.pmed.1003868

Chicago

Karuna, Shelly, Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia, Meg Trahey, et al. 2021. “Neutralizing Antibody Responses over Time in Demographically and Clinically Diverse Individuals Recovered from SARS-CoV-2 Infection in the United States and Peru: A Cohort Study.” PLoS Medicine 18 (12): 1–25. doi:10.1371/journal.pmed.1003868.